About Willmark Pharmaceuticals Private Limited
Data last updated:
Willmark Pharmaceuticals Private Limited is a private limited company based in Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 March 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB1985PTC006176. Its GSTIN is 03AAACW2173M1ZB (Punjab).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Rajiv Bhardwaj (Managing Director) and Rajan Bhardwaj.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Majitha Roadp O Khanna Nagar Amritsar, Punjab, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.49 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹28.63 Lakh (net margin -3%) and EBITDA of ₹24.23 Lakh (EBITDA margin 2.6%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years.
The company has about 15 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Willmark. As per MCA filings, the company has open charges of ₹4.67 Cr on record. Court records list 12 cases involving the company, including 2 filed by the company and 3 filed against it; 5 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website willmarkpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressMajitha Roadp O Khanna Nagar Amritsar, Punjab, India
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Willmark Pharmaceuticals Private Limited
The main business activity of Willmark Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Willmark Pharmaceuticals Private Limited FY 2024 filings available
Willmark Pharmaceuticals Private Limited reported revenue of ₹9.49 Cr (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Willmark Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 5% over three years, including a 7% fall in the latest year. EBITDA fell 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Willmark Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹24.23 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹28.63 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Willmark Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Willmark Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Willmark Pharmaceuticals Private Limited
Willmark Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tulsi Amrit Private Limited | ₹9.54 Cr (FY 2024) | •••• | •••• | 8.0% | •••• | Indore, Madhya Pradesh, India |
| Integrin Healthcare Private Limited | ₹9.54 Cr (FY 2025) | •••• | •••• | 105.0% | •••• | Hyderabad, Telangana, India |
| Steriscience Specialties Private Limited | ₹9.53 Cr (FY 2025) | •••• | •••• | 238.0% | •••• | Thane, Maharashtra, India |
| Athens Labs Limited | ₹9.53 Cr (FY 2025) | •••• | •••• | 843.0% | •••• | Delhi, India |
| Jedaiah Steve Hospital Private Limited | ₹9.5 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Tuticorin, Tamil Nadu, India |
| Willmark Pharmaceuticals Private Limited this company | ₹9.49 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Punjab, India |
| Health Secure (India) Private Limited | ₹9.46 Cr (FY 2021) | •••• | •••• | 0.0% | •••• | Nashik, Maharashtra, India |
| Adnova Healthcare Private Limited | ₹9.45 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Vadodara, Gujarat, India |
| Glory Pharmachem India Private Limited | ₹9.45 Cr (FY 2025) | •••• | •••• | -33.0% | •••• | Hyderabad, Telangana, India |
| Yuvraj Pharmaceuticals Private Limited | ₹9.44 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Delhi, India |
| Guru Mahima Agros Private Limited | ₹9.43 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Bholath, Punjab, India |
Peers are the five companies nearest above and the five nearest below Willmark Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Willmark Pharmaceuticals Private Limited
Willmark Pharmaceuticals Private Limited is audited by KALIA & CO. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KALIA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Willmark Pharmaceuticals Private Limited
Willmark Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajiv Bhardwaj | Managing Director | 14 Mar 1985 | 41 Years 6 Months | Current |
| Rajan Bhardwaj | Director | 01 Apr 1998 | 28 Years 6 Months | Current |
Ownership and Shareholding of Willmark Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Willmark Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Apr 2024 | Hdfc Bank Limited | ₹3.17 Lakh | Open |
| 25 Oct 2023 | Hdfc Bank Limited | ₹6.6 Lakh | Open |
| 20 Jan 2021 | Hdfc Bank Limited | ₹12.07 Lakh | Open |
| 06 Nov 2020 | Hdfc Bank Limited | ₹8.29 Lakh | Open |
| 04 Jul 2017 | Hdfc Bank Limited | ₹3.5 Cr | Open |
Total charge records: 13 View all charges
Legal Cases of Willmark Pharmaceuticals Private Limited
Willmark Pharmaceuticals Private Limited has 12 court cases on record: 2 filed by Willmark Pharmaceuticals, 3 filed against it, 7 where it is another party. 5 cases are pending and 7 are disposed. Status as checked between 29 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 3 | 3 |
| High courts | 4 | 0 | 2 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South, Delhi | Court case (TM) | Filed against the company by Wings Pharmaceuticals Pvt Ltd | Disposed |
| High Court of Punjab and Haryana | Criminal miscellaneous application | Company is another party | Pending |
| District court, SBS Nagar, Punjab | Commercial suit | Filed against the company by State of Punjab | Pending |
| District court, SBS Nagar, Punjab | Criminal case | Company is another party | Pending |
| District court, Tarn Taran, Punjab | Criminal case | Company is another party | Pending |
Full case history
All 12 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Willmark Pharmaceuticals Private Limited
Willmark Pharmaceuticals operates one associated brand: Willmark. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of human and veterinary pharmaceuticals, including tablets, capsules, and animal feed supplements in India. | willmarkpharma.com |
Employees and EPFO Compliance at Willmark Pharmaceuticals Private Limited
Willmark Pharmaceuticals Private Limited has a workforce of 15 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Willmark Pharmaceuticals Private Limited
Willmark Pharmaceuticals Private Limited has 2 board changes on record since 1985: 2 appointments. The latest: Rajan Bhardwaj was appointed as Director on 01 Apr 1998.
8 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Willmark Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Willmark Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Willmark Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Willmark Pharmaceuticals Private Limited
Willmark Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAACW2173M1ZB | Punjab | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Willmark Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Willmark Pharmaceuticals Private Limited
Willmark Pharmaceuticals is an active private limited company based in Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 March 1985 (41+ years old) and is registered under CIN U24232PB1985PTC006176.
Willmark Pharmaceuticals reported revenue of ₹9.49 Cr for FY 2025 (down 7% YoY).
Willmark Pharmaceuticals has 2 current directors:
- Rajiv Bhardwaj - Managing Director
- Rajan Bhardwaj - Director
Willmark Pharmaceuticals reported a net loss of ₹28.63 Lakh (net margin -3%) and EBITDA of ₹24.23 Lakh (EBITDA margin 2.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Willmark Pharmaceuticals is -5% over three years. In the latest year (FY 2025) revenue fell 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Willmark Pharmaceuticals is 03AAACW2173M1ZB, registered in Punjab.
The CIN (Corporate Identification Number) of Willmark Pharmaceuticals is U24232PB1985PTC006176. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Willmark Pharmaceuticals has 12 court cases on record: 2 filed by the company and 3 filed against it. 5 are pending. Most are in the district courts.
Willmark Pharmaceuticals was incorporated on 14 March 1985, making it 41+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Willmark Pharmaceuticals by revenue are Tulsi Amrit Private Limited, Integrin Healthcare Private Limited, Steriscience Specialties Private Limited, Athens Labs Limited, Jedaiah Steve Hospital Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Rajan Bhardwaj was appointed as Director on 01 Apr 1998. Rajiv Bhardwaj was appointed as Managing Director on 14 Mar 1985.